Abeona Therapeutics Inc. (ABEO) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day ladies and gentlemen and welcome to the Abiona Therapeutics first quarter 2026 earnings conference call. At this time all participants are on a listen only mode and a question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. And please note, this conference is being recorded. I will now turn the conference over to your host, Mr. Joe Vizzano, Chief Financial Officer at Abiona Therapeutics. Sir, the floor is yours. Thank you, Operator. Good morning, and thank you for joining us on our first quarter 2026 Results and Business Update conference calls. During this call, we will refer to the press release issued this morning announcing the financial results, which is available on our corporate website at www.abionatherapeutics.com. We anticipate making projections and forward-looking statements during today's call, which are made pursuant to the safe harbor provisions of the Federal Securities Law. These forward-looking statements are based on current expectations and are subject to change. Actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including but not limited to those outlined in our Form 10-K and periodic reports filed with the Securities and Exchange Commission. These documents are available on our website at www.aviantherapeutics.com. Joining me on today's call with prepared remarks are Dr. Vishesh Chaudhry, Chief Executive Officer, and Dr. Madhav Basantabhata, Chief Commercial Officer. With that, I will now turn the call over to Dr. Shashadri to kick us off. Thank you, Joe, and good morning, everyone. First, we are excited to share updates on leading indicat...